75 studies found for:    611
Show Display Options
Rank Status Study
1 Completed Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis
Condition: Gastroparesis
Intervention: Drug: GM-611
2 Completed Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis Aggravated
Interventions: Genetic: Stem cells;   Genetic: Placebo
3 Active, not recruiting Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
Condition: Gastric Cancer
Interventions: Drug: Tegafur-gimeracil-oteracil potassium (TS-1);   Drug: Krestin (PSK)
4 Recruiting Lu AE58054 in Patients With Mild to Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Drug: Lu AE58054
5 Enrolling by invitation Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study)
Conditions: Respiratory Insufficiency;   Respiratory Distress Syndrome, Newborn;   Lung Diseases
Interventions: Behavioral: Team approach to sedation management;   Behavioral: Usual approach to sedation management
6 Active, not recruiting Feasibility Study Evaluating Extraorally Delivered Low Level Light Therapy (LLLT) for the Prevention of Oropharyngeal Mucositis in Pediatric Patients Undergoing Myeloablative Hematopoietic Cell Transplantation
Conditions: Oropharyngeal Mucositis;   Myeloablative Hematopoietic Cell Transplantation;   Low Level Light Therapy
Intervention: Device: Low Level Light Therapy
7 Completed Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant Instilled in the Early Postoperative Period in Patients Undergoing TUR-BT
Condition: Bladder Cancer
Intervention: Drug: EOquin®
8 Active, not recruiting Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: adult human mesenchymal stem cells
9 Not yet recruiting Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility
Conditions: Breast Cancer;   Ovarian Cancer
Interventions: Behavioral: Enhanced Internet DA;   Behavioral: Internet DA;   Behavioral: Enhanced Print DA;   Behavioral: Print DA;   Behavioral: Inconclusive Results DA
10 Active, not recruiting Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension
Conditions: Preeclampsia;   Hypertension;   Pregnancy Induced Hypertension
Intervention:
11 Enrolling by invitation Overlay of 3D Scans on Live Fluoroscopy for Endovascular Procedures in the Hybrid OR
Conditions: Abdominal Aortic Aneurysm (AAA),;   Thoracic Aortic Aneurysm (TAA),;   Carotid Stenosis,;   Visceral Artery Aneurysm
Intervention: Other: Endovascular Aortic Repair (EVAR)
12 Completed Flapless Esthetic Crown Lengthening for the Treatment of Excessive Gingival Display
Condition: Gingival Overgrowth
Interventions: Procedure: Open-flap;   Procedure: Flapless
13 Recruiting Intrathecal Hydromorphone for Cesarean Section
Condition: Pain
Intervention: Drug: intrathecal hydromorphone (IT hydromorphone)
14 Terminated Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease
Condition: Celiac Disease
Intervention: Behavioral: Gluten (behaviour)
15 Completed A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Condition: Solid Tumors
Interventions: Drug: MK1775;   Drug: gemcitabine;   Drug: cisplatin;   Drug: carboplatin
16 Active, not recruiting A Study of V503 in Preadolescents and Adolescents (V503-002)
Conditions: Cervical Cancers;   Vulvar Cancer;   Vaginal Cancer;   Genital Lesions;   PAP Test Abnormalities;   HPV Infections
Intervention: Biological: V503
17 Active, not recruiting Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency
Condition: Alpha 1-Antitrypsin Deficiency
Intervention: Biological: rAAV1-CB-hAAT
18 Unknown  Predictive Model of Therapy Outcomes in Breast Cancer Patients
Condition: Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.
Intervention:
19 Completed Transdermal Rotigotine User Surveillance Study
Condition: Idiopathic Parkinson Disease
Intervention:
20 Enrolling by invitation Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy
Condition: Epilepsy
Intervention: Drug: Brivaracetam (BRV)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years